A mutation in CHN-1/CHIP suppresses muscle degeneration in Caenorhabditis elegans

Developmental Biology

Volumn 312, Issue 1, 2007, Pages 193-202

  Nyamsuren, Oyunbileg ^a   Faggionato, Davide ^a   Loch, Wiebke ^a   Schulze, Ekkehard ^a   Baumeister, Ralf ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Caenorhabditis elegans; Duchenne muscular dystrophy; E3 ligase; Proteasome; Protein degradation

Indexed keywords

CHIP; DYSTROPHIN ASSOCIATED PROTEIN; PROTEASOME INHIBITOR; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAENORHABDITIS ELEGANS; CELL DEATH; CELL MOTILITY; DELETION MUTANT; DOWN REGULATION; DUCHENNE MUSCULAR DYSTROPHY; GENE REPRESSION; MUSCLE ATROPHY; MUTATION; NEMATODE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; UBIQUITINATION;

ANIMALIA; CAENORHABDITIS ELEGANS;

EID: 36549087716     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ydbio.2007.09.033     Document Type: Article

References (31)

1. Adachi H., Waza M., Tokui K., Katsuno M., Minamiyama M., Tanaka F., Doyu M., and Sobue G. CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model. J. Neurosci. 27 (2007) 5115-5126
2. Ballinger C.A., Connell P., Wu Y., Hu Z., Thompson L.J., Yin L.Y., and Patterson C. Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol. Cell. Biol. 19 (1999) 4535-4545
3. Bessou C., Giugia J.B., Franks C.J., Holden-Dye L., and Segalat L. Mutations in the Caenorhabditis elegans dystrophin-like gene dys-1 lead to hyperactivity and suggest a link with cholinergic transmission. Neurogenetics 2 (1998) 61-72
4. Bonuccelli G., Sotgia F., Schubert W., Park D.S., Frank P.G., Woodman S.E., Insabato L., Cammer M., Minetti C., and Lisanti M.P. Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins. Am. J. Pathol. 163 (2003) 1663-1675
5. Brenner S. The genetics of Caenorhabditis elegans. Genetics 77 (1974) 71-94
6. Bulfield G., Siller W.G., Wight P.A., and Moore K.J. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. U. S. A. 81 (1984) 1189-1192
7. Campagnola P.J., Millard A.C., Terasaki M., Hoppe P.E., Malone C.J., and Mohler W.A. Three-dimensional high-resolution second-harmonic generation imaging of endogenous structural proteins in biological tissues. Biophys. J. 82 (2002) 493-508
8. Dai Q., Zhang C., Wu Y., McDonough H., Whaley R.A., Godfrey V., Li H.H., Madamanchi N., Xu W., Neckers L., Cyr D., and Patterson C. CHIP activates HSF1 and confers protection against apoptosis and cellular stress. EMBO J. 22 (2003) 5446-5458
9. Ervasti J.M., and Campbell K.P. Membrane organization of the dystrophin-glycoprotein-complex. Cell 66 (1991) 1121-1131
10. Ervasti J.M., and Campbell K.P. A role for the dystrophin-glycoprotein-complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122 (1993) 809-823
11. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
12. Gaud A., Simon J.M., Witzel T., Carre-Pierrat M., Wermuth C.G., and Segalat L. Prednisone reduces muscle degeneration in dystrophin-deficient Caenorhabditis elegans. Neuromuscul. Disord. 14 (2004) 365-370
13. Gieseler K., Grisoni K., and Segalat L. Genetic suppression of phenotypes arising from mutations in dystrophin-related genes in Caenorhabditis elegans. Curr. Biol. 10 (2000) 1092-1097
14. Grisoni K., Martin E., Gieseler K., Mariol M.C., and Segalat L. Genetic evidence for a dystrophin-glycoprotein-complex (DGC) in Caenorhabditis elegans. Gene 294 (2002) 77-86
15. Harfe B.D., Branda C.S., Krause M., Stern M.J., and Fire A. MyoD and the specification of muscle and non-muscle fates during postembryonic development of the C. elegans mesoderm. Development 125 (1998) 2479-2488
16. Herndon L.A., Schmeissner P.J., Dudaronek J.M., Brown P.A., Listner K.M., Sakano Y., Paupard M.C., Hall D.H., and Driscoll M. Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans. Nature 419 (2002) 808-814
17. Hoppe T., Cassata G., Barral J.M., Springer W., Hutagalung A.H., Epstein H.F., and Baumeister R. Regulation of the myosin-directed chaperone UNC-45 by a novel E3/E4-multiubiquitylation complex in C. elegans. Cell 118 (2004) 337-349
18. Imai Y., Soda M., Hatakeyama S., Akagi T., Hashikawa T., Nakayama K.I., and Takahashi R. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol. Cell 10 (2002) 55-67
19. Janiesch P.C., Kim J., Mouysset J., Barikbin R., Lochmüller H., Cassata G., Krause S., and Hoppe T. The ubiquitin-selective chaperone CDC-48/p97 links myosin assembly to human myopathy. Nat. Cell Biol. 9 (2007) 379-390
20. Karpati G., Carpenter S., and Prescott S. Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve 11 (1988) 795-803
21. Koegl M., Hoppe T., Schlenker S., Ulrich H.D., Mayer T.U., and Jentsch S. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 96 (1999) 635-644
22. Lecker S.H., Solomon V., Mitch W.E., and Goldberg A.L. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J. Nutr. 129 (1999) 227S-237S
23. Mariol M.C., Martin E., Chambonnier L., and Segalat L. Dystrophin-dependent muscle degeneration requires a fully functional contractile machinery to occur in C. elegans. Neuromuscul. Disord. 17 (2007) 56-60
24. McKay S.J., Johnsen R., Khattra J., Asano J., Baillie D.L., Chan S., Dube N., Fang L., Goszczynski B., Ha E., Halfnight E., Hollebakken R., Huang P., Hung K., Jensen V., Jones S.J., Kai H., Li D., Mah A., Marra M., McGhee J., Newbury R., Pouzyrev A., Riddle D.L., Sonnhammer E., Tian H., Tu D., Tyson J.R., Vatcher G., Warner A., Wong K., Zhao Z., and Moerman D.G. Gene expression profiling of cells, tissues, and developmental stages of the nematode C. elegans. Cold Spring Harbor Symp. Quant. Biol. 68 (2003) 159-169
25. Megeney L.A., Kablar B., Perry R.L., Ying C., May L., and Rudnicki M.A. Severe cardiomyopathy in mice lacking dystrophin and MyoD. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 220-225
26. Pickart C.M., and Eddins M.J. Ubiquitin: structures, functions, mechanisms. Biochim. Biophys. Acta 1695 (2004) 55-72
27. Rosser M.F., Washburn E., Muchowski P.J., Patterson C., and Cyr D.M. Chaperone functions of the E3 ubiquitin ligase CHIP. J. Biol. Chem. 282 (2007) 22267-22277
28. Springer W., Hoppe T., Schmidt E., and Baumeister R. A Caenorhabditis elegans Parkin mutant with altered solubility couples alpha-synuclein aggregation to proteotoxic stress. Hum. Mol. Genet. 14 (2005) 3407-3423
29. Syntichaki P., and Tavernarakis N. Death by necrosis. Uncontrollable catastrophe, or is there order behind the chaos?. EMBO Rep. 3 (2002) 604-609
30. Waterston R.H., Hirsh D., and Lane T.R. Dominant mutations affecting muscle structure in Caenorhabditis elegans that map near the actin gene cluster. J. Mol. Biol. 180 (1984) 473-496
31. Wehling M., Spencer M.J., and Tidball J.G. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J. Cell Biol. 155 (2001) 123-131